Accessibility settings

This paper is in the following e-collection/theme issue:

RCTs - Pilots/Feasibility Studies (eHealth) (192) Decision Support for Health Professionals (2413) Design of Processes and Workflows (314) Design and Usability of Clinical Software and EHRs (501) Gastroenterology and Hepatology (212) Artificial Intelligence (5150) Artificial Intelligence in Diabetes Care and Prevention (118) Computer-Aided Diagnosis (453)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/90456, first published .
Two doctors review patient chart on laptop in hospital room with patient in background.

An Explainable AI Tool (FibroX) for Detecting Advanced Liver Fibrosis in Adults With Type 2 Diabetes: Protocol for a Pilot Crossover Trial

An Explainable AI Tool (FibroX) for Detecting Advanced Liver Fibrosis in Adults With Type 2 Diabetes: Protocol for a Pilot Crossover Trial

Authors of this article:

Basile Njei1, 2, 3, 4, 5, 6 Author Orcid Image ;   Ulrick Sidney Kanmounye7 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Journals

  1. Xiao T, Chew N, Targher G, Byrne C, Lip G, Zhou X, Zheng M. Global epidemiology of metabolic dysfunction-associated steatotic liver disease: 2026 update. World Journal of Gastroenterology 2026;32(46) View